Testa Gianluca, Giardina Serena Maria Chiara, Culmone Annalisa, Vescio Andrea, Turchetta Matteo, Cannavò Salvatore, Pavone Vito
Department of General Surgery and Medical Surgical Specialties, Section of Orthopaedics and Traumatology, P.O. "Policlinico Gaspare Rodolico", University of Catania, 95123 Catania, Italy.
J Funct Morphol Kinesiol. 2021 Feb 3;6(1):15. doi: 10.3390/jfmk6010015.
Knee osteoarthritis (OA) is a chronic, degenerative, and progressive disease of articular cartilage, producing discomfort and physical disability in older adults. Thirteen percent of elderly people complain of knee OA. Management options for knee OA could be divided into the following categories: conservative, pharmacological, procedural, and surgical. Joint replacement is the gold standard, reserved for severe grades of knee OA, due to its complications rate and increased risk of joint revision. A nonsurgical approach is the first choice in the adult population with cartilage damage and knee OA. Yearly, more than 10% of knee OA-affected patients undergo intra-articular injections of different drugs, especially within three months after OA diagnosis. Several molecules, such as corticosteroids injection, hyaluronic acid (HA), and platelet-rich plasma (PRP), are managed to reduce the symptoms of patients with knee OA. The aim of this review was to offer an overview of intra-articular injections used for the treatment of OA and report the conventional pharmacological products used.
膝关节骨关节炎(OA)是一种慢性、退行性和进行性的关节软骨疾病,会给老年人带来不适和身体残疾。13%的老年人患有膝关节OA。膝关节OA的治疗方法可分为以下几类:保守治疗、药物治疗、手术操作和手术治疗。关节置换是金标准,由于其并发症发生率和关节翻修风险增加,仅适用于重度膝关节OA。非手术方法是成年软骨损伤和膝关节OA患者的首选。每年,超过10%的膝关节OA患者接受不同药物的关节内注射,尤其是在OA诊断后的三个月内。几种药物,如皮质类固醇注射、透明质酸(HA)和富血小板血浆(PRP),被用于减轻膝关节OA患者的症状。本综述的目的是概述用于治疗OA的关节内注射药物,并报告常用的传统药物产品。